Logo image of ZT

ZIMMER ENERGY TRANSITION -A (ZT) Stock Fundamental Analysis

NASDAQ:ZT - Nasdaq - US9895701061 - Common Stock - Currency: USD

10.24  0 (0%)

Fundamental Rating

2

ZT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. ZT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ZT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ZT was profitable.
In the past year ZT had a positive cash flow from operations.
ZT Yearly Net Income VS EBIT VS OCF VS FCFZT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 10M 20M

1.2 Ratios

Industry RankSector Rank
ROA 1.31%
ROE 1.4%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZT Yearly ROA, ROE, ROICZT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 2 -2 4 6 8

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ZT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZT Yearly Profit, Operating, Gross MarginsZT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

5

2. Health

2.1 Basic Checks

ZT has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for ZT has been reduced compared to a year ago.
ZT Yearly Shares OutstandingZT Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 10M 20M 30M 40M
ZT Yearly Total Debt VS Total AssetsZT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 100M 200M 300M

2.2 Solvency

ZT has an Altman-Z score of 11.77. This indicates that ZT is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for ZT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.77
ROIC/WACCN/A
WACCN/A
ZT Yearly LT Debt VS Equity VS FCFZT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 100M 200M 300M

2.3 Liquidity

ZT has a Current Ratio of 0.36. This is a bad value and indicates that ZT is not financially healthy enough and could expect problems in meeting its short term obligations.
ZT has a Quick Ratio of 0.36. This is a bad value and indicates that ZT is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.36
ZT Yearly Current Assets VS Current LiabilitesZT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

ZT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -66.19%.
EPS 1Y (TTM)-66.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-97%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZT Yearly Revenue VS EstimatesZT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022
ZT Yearly EPS VS EstimatesZT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 93.09, ZT can be considered very expensive at the moment.
ZT is valuated expensively when we compare the Price/Earnings ratio to 28.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 93.09
Fwd PE N/A
ZT Price Earnings VS Forward Price EarningsZT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 73.17
EV/EBITDA N/A
ZT Per share dataZT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZIMMER ENERGY TRANSITION -A

NASDAQ:ZT (6/15/2023, 8:00:03 PM)

10.24

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners51.12%
Inst Owner Change-14.57%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap441.60M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 93.09
Fwd PE N/A
P/S N/A
P/FCF 73.17
P/OCF 73.17
P/B 1.33
P/tB 1.33
EV/EBITDA N/A
EPS(TTM)0.11
EY1.07%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.14
FCFY1.37%
OCF(TTM)0.14
OCFY1.37%
SpS0
BVpS7.69
TBVpS7.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.31%
ROE 1.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 130.4%
Current Ratio 0.36
Quick Ratio 0.36
Altman-Z 11.77
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y365.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y365.11%
OCF growth 3YN/A
OCF growth 5YN/A